Overview of comments received on 'Draft ICH guideline M7 on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk - Addendum - Step 2b'(收到的关于“ICH 指南 M7 草案关于评估和控制药物中 DNA 反应性（诱变）杂质以限制潜在致癌风险 - 附录 - 步骤 2b”的评论概述)